Funding for this research was provided by:
Text and Data Mining valid from 2019-07-11
Received: 3 March 2019
Accepted: 20 June 2019
First Online: 11 July 2019
Ethics approval and consent to participate
: This study is conducted according to the principles of the Declaration of Helsinki 2013 and the International Conference on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guideline for Good Clinical Practice E6 (R2) 2016. Prior to undertaking any study-related procedures, each participant receives a verbal and written explanation of study aims, methods, potential hazards and benefits from investigators, and provides written informed consent. Separate consent is obtained for the optional genetics component. Ethics approval has been obtained from the Human Research Ethics Committee (HREC) of the Western Sydney Local Health District (reference HREC/17/WMEAD/490).
: Not applicable.
: The authors declare that they have no competing interests.